Herzinsuffizienz, VAD, Herztransplantation - FINeST
Herzinsuffizienz, VAD, Herztransplantation - FINeST
Herzinsuffizienz, VAD, Herztransplantation - FINeST
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
POST-HEART TRANSPLANT MORBIDITY FOR ADULTS Cumulative Prevalence<br />
in Survivors within 1 and 5 Years<br />
Post-Transplant (Transplants: 2000 - June 2005)<br />
Outcome<br />
2. Januar 2012<br />
Within 1<br />
Year<br />
Total N with<br />
known response<br />
Within 5<br />
Years<br />
Total N with known<br />
response<br />
Hypertension 75.1% (N = 3,273) 89.5% (N = 3,273)<br />
Renal Dysfunction 26.3% (N = 3,273) 28.9% (N = 3,273)<br />
Abnormal Creatinine < 2.5 mg/dl 20.7% 22.1%<br />
Creatinine > 2.5 mg/dl 4.8% 5.0%<br />
Chronic Dialysis 0.5% 1.5%<br />
Renal Transplant 0.3% 0.3%<br />
Hyperlipidemia 73.4% (N = 3,273) 90.7% (N = 3,273)<br />
Diabetes 28.0% (N = 3,273) 40.0% (N = 3,273)<br />
Cardiac Allograft Vasculopathy 5.4% (N = 3,273) 27.1% (N = 3,273)<br />
ISHLT<br />
J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132
Change language